You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PI3K inhibitor

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

Not yet recruiting
  • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
  • Zhoukou, Henan, China
  • +1 more
Dec 22, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

3rd Line GIST Trial in Worldwide (ST571 + BYL719)

Completed
  • 3rd Line GIST
  • ST571 + BYL719
  • Portland, Oregon
  • +10 more
Dec 17, 2020

Inert Non Hodgkin's Lymphoma Trial in Beijing (IBI376, Rituximab)

Recruiting
  • Inert Non Hodgkin's Lymphoma
  • Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Feb 19, 2022

3rd Line GIST Trial in Worldwide (STI571, BKM120)

Completed
  • 3rd Line GIST
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

Follicular Lymphoma Trial in Shanghai (Duvelisib)

Unknown status
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Jan 10, 2021

Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in

Completed
Has Results
  • Endometrial Endometrioid Adenocarcinoma
  • +5 more
  • New Haven, Connecticut
  • +42 more
Jan 25, 2022

Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 20, 2022

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Bulgaria, Georgia, Poland (Tenalisib)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Pleven, Bulgaria
  • +5 more
Jul 22, 2021

Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)

Recruiting
  • Leukemia, Acute Lymphocytic
  • Durham, North Carolina
    Duke Cancer Center
Jun 28, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago (drug, biological, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 25, 2020

Alzheimer Trial in Hialeah, Maitland, Winter Park ([18F]PI-2620)

Recruiting
  • Alzheimer Disease
  • Hialeah, Florida
  • +2 more
Jan 18, 2023

PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
Feb 10, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
Apr 22, 2022

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Solid Tumor, Adult Trial in Seoul (TAS-117)

Completed
  • Solid Tumor, Adult
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 21, 2021

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
Oct 3, 2022

Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 13, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)

Active, not recruiting
  • Breast Cancer, PI3K, Alpelisib
  • Angers, France
  • +13 more
Mar 8, 2022

Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

Completed
Has Results
  • Neoplasm
  • PF-05212384 (gedatolisib)
  • +3 more
  • Birmingham, Alabama
  • +28 more
Sep 9, 2021